
|Articles|March 25, 2022
Daily Medication Pearl: Donepezil (Aricept)
Author(s)Saro Arakelians, PharmD
Donepezil (Aricept) is an acetylcholinesterase inhibitor indicated for the treatment of dementia related to Alzheimer disease.
Advertisement
Medication Pearl of the Day: Donepezil (Aricept)
Indication: Donepezil (Aricept) is an acetylcholinesterase inhibitor indicated for the treatment of dementia related to Alzheimer disease. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer disease.
Insight:
- Dosing: 5 mg or 10 mg administered once daily.
- Dosage forms: Tablets 5 mg, 10 mg, and 23 mg. Orally disintegrating tablets 5 mg and 10 mg.
- Adverse events: The most common adverse reactions in clinical studies of donepezil are nausea, diarrhea, insomnia, vomiting, muscle cramps, fatigue, and anorexia.
- Mechanism of action: Donepezil hydrochloride is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by acetylcholinesterase.
- Manufacturer: Eisai Pharma
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
4
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
5